Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Analysis: Key Insights on Growth Rates, Trends, and Major Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What CAGR Will the Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Achieve During 2025–2034, and What Does It Indicate?
The lateral flow immunoassay (LFIA) based rapid test market has declined sharply in recent years. It is forecasted to decrease from $8.03 billion in 2025 to $7.23 billion in 2025, at a CAGR of -9.9%. This decline is due to issues such as limited sensitivity and specificity, challenges with multiplexing, cross-reactivity, storage and shelf-life limitations, and lack of quantitative capability.
The lateral flow immunoassay (LFIA) based rapid test market is expected to see steady growth, reaching $8.3 billion by 2029 at a CAGR of 3.5%. Growth will be impacted by global supply chain disruptions and regulatory challenges, but trends will focus on advanced technology for testing, partnerships, at-home test kits, AI-based screening, and affordable test options.
Which Primary Drivers Are Supporting the Continued Expansion of the lateral flow immunoassay (lfia) based rapid test Market?
Quality control issues are hindering the growth of the lateral flow immunoassay (LFIA) based rapid test market. Operational costs, such as salaries and technology investments, have placed pressure on many firms’ profit margins. In June 2023, PLOS reported that some LFIA tests on the market fail to meet high reliability and specificity standards. A review of four LFIA tests showed varying diagnostic performances, with some tests having as low as 47% accuracy for IgG detection.
Explore Comprehensive Insights Into The Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3293&type=smp
Who Are the Key Firms Paving the Way for Growth in the Lateral Flow Immunoassay (LFIA) Based Rapid Test Market?
Major companies operating in the lateral flow immunoassay (LFIA) based rapid test market include:
• Abbott Laboratories_x000D_
• F. Hoffmann-La Roche_x000D_
• Quidel Corporation_x000D_
• Becton_x000D_
• Dickinson and Company_x000D_
What Are the Most Influential Trends Currently Shaping the Lateral Flow Immunoassay (LFIA) Based Rapid Test Market?
In the lateral flow immunoassay market, companies are adopting technologies like qPCR to improve test sensitivity and speed. F. Hoffmann-La Roche AG launched the LightCycler PRO System in November 2023, offering precise and reliable diagnostic tools for healthcare.
Secure Your Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report Now for Fast and Efficient Delivery!
How Are the Key Segments of the Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Impacting Its Expansion and Revenue Streams?
The lateral flow immunoassay (LFIA) based rapid test market covered in this report is segmented –
1) By Technique: Competitive Assay, Sandwich Assay, Multiplex Detection Assay
2) By Application: Infectious Disease, Pregnancy And Fertility, Toxicology, Cardiac Marker And Cholesterol Testing, Other Applications
3) By End-Users: Hospitals And Clinics, Diagnostic Laboratories, Home Care, Other End Users
Subsegments:
1) By Competitive Assay: Direct Competitive Assays, Indirect Competitive Assays
2) By Sandwich Assay: Single-step Sandwich Assays, Two-step Sandwich Assays
3) By Multiplex Detection Assay: Multi-analyte Assays, Simultaneous Detection Of Various Targets
Which Regions Are Essential for the Growth of the Lateral Flow Immunoassay (LFIA) Based Rapid Test Market?
North America was the largest region in the lateral flow immunoassay (LFIA) based rapid test market in 2025. Asia-Pacific was the second largest region in the global lateral flow immunoassay (LFIA) based rapid test market. The regions covered in the lateral flow immunoassay (LFIA) based rapid test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
How Is the Definition of the Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Impacting Future Growth?
Lateral Flow Immunoassay (LFIA) based rapid test is a simple technology-based diagnostic device that is used to determine the presence of a target such as pathogens or biomarkers in samples collected from the human body. These samples may include urine, saliva, blood, sweat and other fluids.
Browse Through More Similar Reports By The Business Research Company:
Veterinary Laboratory Testing Services Global Market Report 2025
Pharma Microbiology Testing Kits Global Market Report 2025
Veterinary Diagnostic Equipment Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
